Cargando…
Regional differences in patient characteristics and outcomes during uninterrupted anticoagulation with dabigatran versus warfarin in catheter ablation of atrial fibrillation: the RE-CIRCUIT study
PURPOSE: To describe regional differences in patient characteristics, ablation procedures, and bleeding events in the RE-CIRCUIT study. RE-CIRCUIT was a prospective, multicenter study that captured data from different regions, providing an opportunity to understand the practices followed in various...
Autores principales: | Hohnloser, Stefan H., Calkins, Hugh, Willems, Stephan, Verma, Atul, Schilling, Richard, Okumura, Ken, Nordaby, Matias, Kleine, Eva, Biss, Branislav, Gerstenfeld, Edward P. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer US
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6660508/ https://www.ncbi.nlm.nih.gov/pubmed/30758702 http://dx.doi.org/10.1007/s10840-019-00518-x |
Ejemplares similares
-
Heparin dosing in uninterrupted anticoagulation with dabigatran vs. warfarin in atrial fibrillation ablation: RE-CIRCUIT study
por: Calkins, Hugh, et al.
Publicado: (2019) -
Comparison of uninterrupted anticoagulation with dabigatran etexilate or warfarin in the periprocedural period for atrial fibrillation catheter ablation: Results of the Japanese subgroup of the RE‐CIRCUIT trial
por: Yoshida, Yukihiko, et al.
Publicado: (2018) -
Uninterrupted dabigatran is safer than warfarin in patients undergoing
ablation for atrial fibrillation
por: Spartalis, Michael, et al.
Publicado: (2017) -
Effects of uninterrupted dabigatran on the intensity of anticoagulation during atrial fibrillation ablation
por: Osawa, Takumi, et al.
Publicado: (2021) -
Uninterrupted rivaroxaban vs. uninterrupted vitamin K antagonists for catheter ablation in non-valvular atrial fibrillation
por: Cappato, Riccardo, et al.
Publicado: (2015)